D-Dimer Determined Anticoagulation INTENSITY in Patients With Mechanical Valve Replacement
NCT01996657 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 772
Last updated 2017-06-26
Summary
The optimal intensity of oral anticoagulation in China patients undergoing mechanical valve replacements is still controversial due to the different risk profiles of thrombophilia and bleeding in Chinese patients. Elevated D-dimer could reflect a pro-thrombogenic or prothrombotic state, and thus might be used to decide the intensity of oral anticoagulation.
This study was to evaluate whether elevated D-dimer levels could help to determine the intensity of oral anticoagulation in patients with mechanical heart valve prostheses.
Conditions
- Heart Valve Disease
Interventions
- DRUG
-
Warfarin
Sponsors & Collaborators
-
Wuhan Asia Heart Hospital
lead OTHER
Principal Investigators
-
zhang zhenlu, PH.D · Wuhan Asia Heart Hospital
-
Zhou xin, Doctor · Wuhan Asia Heart Hospital
-
liu ze jin, PH.D · Wuhan Asia Heart Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2016-05-31
- Completion
- 2016-06-30
Countries
- China
Study Locations
More Related Trials
-
Optimizing Health Outcomes in Patients With Symptomatic Aortic Valve Disease
NCT02266251 ·Status: COMPLETED
-
Study of Blood Clotting After Transcatheter Atrial Septal Defect Closure
NCT01086046 ·Status: UNKNOWN ·Phase: NA
-
Hypothyroidism After the TAVI Procedure in Elderly Patients
NCT04831957 ·Status: RECRUITING ·Phase: NA
-
Treatment of Concomitant Mitral Regurgitation by Mitral Valve Clipping in Patients With Successful Transcatheter Aortic Valve Implantation.
NCT04009434 ·Status: UNKNOWN ·Phase: NA
-
Outcome, Recuperation and Hemodynamics in Aortic Stenosis
NCT05272020 ·Status: UNKNOWN ·Phase: NA
-
Patient International Normalised Ratio (INR) Self-Testing Program
NCT00925197 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial in China
NCT05580952 ·Status: UNKNOWN ·Phase: NA
-
Danish National Randomized Study on Early Aortic Valve Replacement in Patients With Asymptomatic Severe Aortic Stenosis
NCT03972644 ·Status: RECRUITING ·Phase: NA
-
Change in Coronary Microcirculation and FFR After TAVI in Patients With Cardiovascular Comorbidities
NCT04663334 ·Status: COMPLETED
-
The Effect of Transaortic Valve Replacement on the Endothelial Integrity and Function
NCT01993485 ·Status: COMPLETED
-
Geriatric Assessment and Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement
NCT03173079 ·Status: COMPLETED
-
Sodium Creatine Phosphate in Heart Valve Surgery
NCT03186053 ·Status: UNKNOWN ·Phase: NA
-
Incidence of Hemocompatibility Events With or Without Aspirin in Patients With CH-VAD
NCT07343102 ·Status: COMPLETED
-
Assessment of Myocardial Fibrosis in Aortic STenosis
NCT02316587 ·Status: COMPLETED
-
Efficacy and Safety of Rivaroxaban in the Early Postoperative Period for Patients With Bioprosthetic Valves
NCT06476301 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis
NCT03566303 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement
NCT05739253 ·Status: RECRUITING
-
Outcomes for Patients With Ascending Aortic Dilation Who Underwent TAVR
NCT07148973 ·Status: COMPLETED
-
Prospective Observational Cohort Study of Moderate Aortic Valve Disease
NCT06595992 ·Status: RECRUITING
-
The Dutch Asymptomatic Mitral Regurgitation Trial
NCT01708265 ·Status: TERMINATED ·Phase: NA
-
Observatory of Anticoagulation After Bioprosthetic Aortic Valve Replacement
NCT01293188 ·Status: COMPLETED
-
STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant
NCT06901466 ·Status: RECRUITING ·Phase: PHASE4
-
Myocardial Efficiency of the Left Ventricle in Asymptomatic Patients With Aortic Valve Stenosis - a Prognostic Marker and a Target for Intervention?
NCT02076711 ·Status: COMPLETED ·Phase: PHASE2
-
Stroke Volume Analysis During Aortic Valve Replacement Trial
NCT02156856 ·Status: UNKNOWN
-
Blood Transfusion Management in Patients With Mitral Valve Replacement in China
NCT03885570 ·Status: UNKNOWN